EGFR and pituitary tumor: Finally, to validate that Cushing phenotype was due to the EGFR upregulation, these transgenic mice were treated with an EGFR inhibitor, such as gefitinib: Treated mice displayed a diminished pituitary tumor size and lower plasma glucose levels.